Literature DB >> 6446387

A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.

E R Pavillard, H Miles.   

Abstract

The minimum inhibitory concentrations (MICs) of cefoperazone for 507 clinical isolates of Pseudomonas aeruginosa were measured by plate dilution technique. On a cumulative percentage basis, 81% of isolates were inhibited by less than or equal 3.13 microgram/ml of cefoperazone. The minimum bactericidal concentration (MBC) was found to be generally twice the MIC. Synergy occurred between cefoperazone and tobramycin, judged by a lowering of the MIC in 69% of isolates, for which the MIC of cefoperazone alone was less than or equal to 6.2 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446387

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  4 in total

1.  Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.

Authors:  K Takahashi; H Kanno
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

2.  The role of the laboratory in the planned use of cefoperazone for the treatment of difficult Pseudomonas infections.

Authors:  M McDonald; H Miles; M Carson
Journal:  Drugs       Date:  1981       Impact factor: 9.546

Review 3.  Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

4.  Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.

Authors:  H M Miles; M Carson; E R Pavillard
Journal:  Drugs       Date:  1981       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.